Idogen handelsstoppad på Spotlight | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare
Idogen appoints Anders Karlsson as new CEO - Idogen
Board and Advisors | Ambulero
Idogen's Historical Milestones - Idogen
40/20 – Information regarding the rights issue from Idogen AB
Idogen aktieägargrupp | Facebook
PRESS RELEASE IDOGEN AB
Idogen's Historical Milestones - Idogen
Idogen AB Interim report Idogen AB Interim report
Investors Home
Idogen's Historical Milestones - Idogen
Trading Direkt analyserar bolagen på Spotlight 2019-06-19: Touchtech & Idogen - YouTube
Idogen Year end report 3 - Idogen
Annual Report
Idogen files patent application for new tolerogenic cell therapy
Crown Princess and Prince Daniel visited Idogen - Idogen
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
ANNUAL REPORT
Idogen AB Interim report
Idogen AB (publ) Corp. Reg. No.
Idogen publishes prospectus in connection with the forthcoming rights issue - Nordic Life Science – the leading Nordic life science news service
Idogen's Historical Milestones - Idogen
Idogen's Historical Milestones - Idogen
